---
abstract: Recent studies suggest that thousands of genes may contribute to breast
  cancer pathophysiologies when deregulated by genomic or epigenomic events. Here,
  we describe a model amp quot system amp quot to appraise the functional contributions
  of these genes to breast cancer subsets. In general, the recurrent genomic and transcriptional
  characteristics of 51 breast cancer cell lines mirror those of 145 primary breast
  tumors, although some significant differences are documented. The cell lines that
  comprise the system also exhibit the substantial genomic, transcriptional, and biological
  heterogeneity found in primary tumors. We show, using Trastuzumab Herceptin monotherapy
  as an example, that the system can be used to identify molecular features that predict
  or indicate response to targeted therapies or other physiological perturbations.
authors: Neve RM, Chin K, Fridlyand J, Yeh J, Baehner FL, Fevr T, Clark L, Bayani
  N, Coppe JP, Tong F, Speed T, Spellman PT, DeVries S, Lapuk A, Wang NJ, Kuo WL,
  Stilwell JL, Pinkel D, Albertson DG, Waldman FM, McCormick F, Dickson RB, Johnson
  MD, Lippman M, Ethier S, Gazdar A and Gray JW.
cancertypes:
- samples_arraymap: ~
  samples_progenetix: 2
  term_id: ncit:C27949
  term_label: ~
- samples_arraymap: ~
  samples_progenetix: 8
  term_id: ncit:C2852
  term_label: Adenocarcinoma
- samples_arraymap: ~
  samples_progenetix: 11
  term_id: ncit:C2916
  term_label: Carcinoma
- samples_arraymap: 2
  samples_progenetix: ~
  term_id: ncit:C4001
  term_label: Inflammatory Breast Carcinoma
- samples_arraymap: 46
  samples_progenetix: 27
  term_id: ncit:C4017
  term_label: Ductal Breast Carcinoma
- samples_arraymap: 3
  samples_progenetix: ~
  term_id: ncit:C4872
  term_label: Breast Carcinoma
- samples_arraymap: 1
  samples_progenetix: ~
  term_id: ncit:C5160
  term_label: Mixed Lobular and Ductal Breast Carcinoma
- samples_arraymap: 1
  samples_progenetix: 5
  term_id: ncit:null
  term_label: 'null'
- samples_arraymap: 1
  samples_progenetix: 1
  term_id: pgx:icdom:0000_0
  term_label: not in ICD-O (e.g. non-neoplastic, reference)
- samples_arraymap: ~
  samples_progenetix: 11
  term_id: pgx:icdom:8010_3
  term_label: Carcinoma, NOS
- samples_arraymap: 1
  samples_progenetix: 1
  term_id: pgx:icdom:8021_3
  term_label: Carcinoma, anaplastic, NOS
- samples_arraymap: ~
  samples_progenetix: 8
  term_id: pgx:icdom:8140_3
  term_label: Adenocarcinoma, NOS
- samples_arraymap: 46
  samples_progenetix: 27
  term_id: pgx:icdom:8500_3
  term_label: Infiltrating duct carcinoma, NOS
- samples_arraymap: 1
  samples_progenetix: 1
  term_id: pgx:icdom:8524_3
  term_label: Infiltrating lobular mixed with other types of carcinoma
- samples_arraymap: 2
  samples_progenetix: 2
  term_id: pgx:icdom:8530_3
  term_label: Inflammatory carcinoma
- samples_arraymap: 2
  samples_progenetix: 2
  term_id: pgx:icdom:8575_3
  term_label: Metaplastic carcinoma, NOS
- samples_arraymap: 52
  samples_progenetix: 53
  term_id: pgx:icdot:C50.9
  term_label: Breast, NOS
- samples_arraymap: 1
  samples_progenetix: ~
  term_id: pgx:icdot:C76
  term_label: ill-defined
- samples_arraymap: 52
  samples_progenetix: 52
  term_id: pgx:seer:26000
  term_label: Breast
- samples_arraymap: 1
  samples_progenetix: 1
  term_id: pgx:seer:99999
  term_label: invalid
- samples_arraymap: 1
  samples_progenetix: 1
  term_id: snmi:M-00000
  term_label: not in ICD-O (e.g. non-neoplastic, reference)
- samples_arraymap: ~
  samples_progenetix: 11
  term_id: snmi:M-80103
  term_label: Carcinoma, NOS
- samples_arraymap: 1
  samples_progenetix: 1
  term_id: snmi:M-80213
  term_label: Carcinoma, anaplastic, NOS
- samples_arraymap: ~
  samples_progenetix: 8
  term_id: snmi:M-81403
  term_label: Adenocarcinoma, NOS
- samples_arraymap: 46
  samples_progenetix: 27
  term_id: snmi:M-85003
  term_label: Infiltrating duct carcinoma, NOS
- samples_arraymap: 1
  samples_progenetix: 1
  term_id: snmi:M-85243
  term_label: Infiltrating lobular mixed with other types of carcinoma
- samples_arraymap: 2
  samples_progenetix: 2
  term_id: snmi:M-85303
  term_label: Inflammatory carcinoma
- samples_arraymap: 2
  samples_progenetix: 2
  term_id: snmi:M-85753
  term_label: Metaplastic carcinoma, NOS
contact:
  email: jwgray@lbl.gov
  name: Joe W. Gray
counts:
  biosamples: 53
  samples_acgh: 53
  samples_ccgh: 0
  samples_wes: 0
  samples_wgs: 0
external_identifiers:
- pubmed:17157791
geo_data:
  geo_json:
    coordinates:
    - -122.42
    - 37.77
    type: Point
  info:
    city: San Francisco
    continent: North America
    country: United States
    label: San Francisco, United States, North America
    precision: city
journal: 'Cancer Cell 10, 6 (2006): 515-27.'
label: 'Neve et al. (2006): A Collection of Breast Cancer Cell Lines for the Study
  of Functionally Distinct Cancer ...'
notes: ~
pmid: 17157791
title: A Collection of Breast Cancer Cell Lines for the Study of Functionally Distinct
  Cancer Subtypes.
year: 2006
